Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 444

1.

Paraganglioma of the urinary bladder: can biologic potential be predicted?

Cheng L, Leibovich BC, Cheville JC, Ramnani DM, Sebo TJ, Neumann RM, Nascimento AG, Zincke H, Bostwick DG.

Cancer. 2000 Feb 15;88(4):844-52.

PMID:
10679654
2.

Smooth muscle neoplasms of the urinary bladder: a clinicopathologic comparison of leiomyoma and leiomyosarcoma.

Martin SA, Sears DL, Sebo TJ, Lohse CM, Cheville JC.

Am J Surg Pathol. 2002 Mar;26(3):292-300.

PMID:
11859200
3.

Inverted urothelial papilloma: is ploidy, MIB-1 proliferative activity, or p53 protein accumulation predictive of urothelial carcinoma?

Cheville JC, Wu K, Sebo TJ, Cheng L, Riehle D, Lohse CM, Shane V.

Cancer. 2000 Feb 1;88(3):632-6.

PMID:
10649258
4.

Inflammatory pseudotumor and sarcoma of urinary bladder: differential diagnosis and outcome in thirty-eight spindle cell neoplasms.

Iczkowski KA, Shanks JH, Gadaleanu V, Cheng L, Jones EC, Neumann R, Nascimento AG, Bostwick DG.

Mod Pathol. 2001 Oct;14(10):1043-51.

6.

Prognostic significance of p53, bcl-2 and Ki-67 in high risk superficial bladder cancer.

Stavropoulos NE, Filiadis I, Ioachim E, Hastazeris K, Tsimaris I, Kalogeras D, Stefanaki S, Agnantis NJ.

Anticancer Res. 2002 Nov-Dec;22(6B):3759-64.

PMID:
12552989
7.

Atypical nephrogenic metaplasia of the urinary tract: a precursor lesion?

Cheng L, Cheville JC, Sebo TJ, Eble JN, Bostwick DG.

Cancer. 2000 Feb 15;88(4):853-61.

PMID:
10679655
8.

Metastatic renal cell carcinoma to the bladder: a clinicopathologic and immunohistochemical study.

Sim SJ, Ro JY, Ordonez NG, Park YW, Kee KH, Ayala AG.

Mod Pathol. 1999 Apr;12(4):351-5.

PMID:
10229498
9.
10.

Clinicopathologic and DNA cytometric analysis of carcinoid tumors of the thymus.

Goto K, Kodama T, Matsuno Y, Yokose T, Asamura H, Kamiya N, Shimosato Y.

Mod Pathol. 2001 Oct;14(10):985-94.

11.

Salivary gland malignant myoepithelioma: a clinicopathologic and immunohistochemical study of ten cases.

Nagao T, Sugano I, Ishida Y, Tajima Y, Matsuzaki O, Konno A, Kondo Y, Nagao K.

Cancer. 1998 Oct 1;83(7):1292-9.

PMID:
9762928
12.

Paraganglioma of the urinary bladder.

Nesi G, Vezzosi V, Amorosi A, Menghetti I, Selli C.

Urol Int. 1996;56(4):250-3.

PMID:
8776825
13.

Neurofibroma of the urinary bladder.

Cheng L, Scheithauer BW, Leibovich BC, Ramnani DM, Cheville JC, Bostwick DG.

Cancer. 1999 Aug 1;86(3):505-13. Review.

PMID:
10430260
14.

P53 expression in small cell carcinoma of the urinary bladder: biological and prognostic implications.

Wang X, Jones TD, Maclennan GT, Yang XJ, Lopez-Beltran A, Eble JN, Koch MO, Lin H, Baldridge LA, Tretiakova M, Cheng L.

Anticancer Res. 2005 May-Jun;25(3B):2001-4.

15.
16.

Prognostic value of p53 and MIB-1 in transitional cell carcinoma of the urinary bladder with regional lymph node involvement.

Frank I, Cheville JC, Blute ML, Lohse CM, Karnes RJ, Weaver AL, Sebo TJ, Nehra A, Zincke H.

Cancer. 2004 Oct 15;101(8):1803-8.

17.

Pigmented extraadrenal paragangliomas. A clinicopathologic and immunohistochemical study of five cases.

Moran CA, Albores-Saavedra J, Wenig BM, Mena H.

Cancer. 1997 Jan 15;79(2):398-402.

PMID:
9010114
18.

Biomarker study of primary nonmetastatic versus metastatic invasive bladder cancer. National Cancer Institute Bladder Tumor Marker Network.

Lianes P, Charytonowicz E, Cordon-Cardo C, Fradet Y, Grossman HB, Hemstreet GP, Waldman FM, Chew K, Wheeless LL, Faraggi D.

Clin Cancer Res. 1998 May;4(5):1267-71.

19.

Squamous cell carcinoma of the urinary bladder: a clinicopathologic and immunohistochemical study of 16 cases.

Guo CC, Gomez E, Tamboli P, Bondaruk JE, Kamat A, Bassett R, Dinney CP, Czerniak BA.

Hum Pathol. 2009 Oct;40(10):1448-52. doi: 10.1016/j.humpath.2009.03.005. Epub 2009 May 19.

PMID:
19454359

Supplemental Content

Support Center